These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9553657)

  • 21. Perspectives from American Society of Clinical Oncology: translational and clinical research highlights in breast and colorectal cancers.
    Fontanella C; Aprile G; Scartozzi M; Lederer B; Cascinu S; von Minckwitz G
    Future Oncol; 2014 Oct; 10(12):1901-6. PubMed ID: 25386808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer.
    Buzdar A; Chlebowski R; Cuzick J; Duffy S; Forbes J; Jonat W; Ravdin P
    Curr Med Res Opin; 2006 Aug; 22(8):1575-85. PubMed ID: 16870082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era.
    Colozza M; de Azambuja E; Cardoso F; Bernard C; Piccart MJ
    Oncologist; 2006 Feb; 11(2):111-25. PubMed ID: 16476832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The academic global virtual concept in clinical cancer research and its application to breast cancer: The Breast Cancer International Research Group.
    Nabholtz JM; Lindsay MA; Hugh J; Mackey J; Smylie M; Au HJ; Tonkin K; Allen M
    Semin Oncol; 1999 Jun; 26(3 Suppl 8):4-8. PubMed ID: 10403467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translational research and the changing face of breast cancer.
    Dowsett M
    Breast Cancer Res Treat; 2004; 87 Suppl 1():S1-2. PubMed ID: 15597214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. kConFab: a familial breast cancer consortium facilitating research and translational oncology.
    Thorne H; Mitchell G; Fox S;
    J Natl Cancer Inst Monogr; 2011; 2011(43):79-81. PubMed ID: 22043047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New strategies in estrogen receptor-positive breast cancer.
    Johnston SR
    Clin Cancer Res; 2010 Apr; 16(7):1979-87. PubMed ID: 20332324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
    Jankowitz RC; McGuire KP; Davidson NE
    Breast; 2013 Aug; 22 Suppl 2():S165-70. PubMed ID: 24074781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proceedings of the First Global Workshop on Breast Cancer: pathways to the evaluation and clinical development of novel agents for breast cancer.
    Albain KS; Carey L; Gradishar WJ; Gralow JR; Lipton A; Rugo H; Tripathy D; Peck S; Abair T; Pegram M
    Clin Breast Cancer; 2010 Dec; 10(6):421-39. PubMed ID: 21147685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current status of treatment for early-stage invasive breast cancer].
    Kásler M; Polgár C; Fodor J
    Orv Hetil; 2009 May; 150(22):1013-21. PubMed ID: 19465349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conclusions: future strategies in the treatment of breast cancer.
    Piccart MJ; Hortobagyi GN
    Semin Oncol; 1997 Feb; 24(1 Suppl 3):S34-40. PubMed ID: 9071339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adjuvant chemotherapy of early stage breast cancer].
    Boér K
    Orv Hetil; 2010 Feb; 151(9):344-53. PubMed ID: 20159750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.
    Fidler IJ
    Cancer Res; 1990 Oct; 50(19):6130-8. PubMed ID: 1698118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Issues in clinical research for metastatic breast cancer.
    Dogan S; Andre F; Arnedos M
    Curr Opin Oncol; 2013 Nov; 25(6):625-9. PubMed ID: 24097109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Herceptin in primary breast cancer: views from North America and Europe.
    Leyland-Jones B; Smith I
    Oncology; 2001; 61 Suppl 2():83-91. PubMed ID: 11694792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fifty years of systemic therapy for breast cancer: from one size fits all to tailored therapy.
    Burstein HJ
    Am Soc Clin Oncol Educ Book; 2014; ():e1-3. PubMed ID: 24857085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian ablation as treatment for young women with breast cancer.
    Davidson NE
    J Natl Cancer Inst Monogr; 1994; (16):95-9. PubMed ID: 7528032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
    Goss PE; Strasser K
    Drugs; 2002; 62(6):957-66. PubMed ID: 11929341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.